What the agency says to do
FDA’s record gives no instruction for consumers.
Status: Ongoing. What the FDA’s recall statuses mean (opens in a new tab)
Note from Recalls Watch, not agency text
- Talk to your pharmacist or doctor before you stop taking a medicine. FDA: Medication Guides and your medicines (opens in a new tab)
- In an emergency call 911. For a possible poisoning call Poison Help at 1-800-222-1222. Poison Help (HRSA) (opens in a new tab)
- For refunds, repairs or replacements, follow the agency notice. Recalls.gov (opens in a new tab)
Why it was recalled
Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.
FDA classification: Class I. What the FDA’s classes mean (opens in a new tab)
The recalled product
Codes in the record. Click one to copy it.
Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-401-10.
- Lot or code
- Lots: GY825029, GY825030, GY825031, GY825032, expires: 2028-OCT
- FDA recall number
- D-0732-2026
- Quantity
- 34,020 100-count bottles.
Distribution (FDA): Nationwide in the USA
Source
- Issued by
- U.S. Food and Drug Administration
- Firm
- JB Chemicals and Pharmaceuticals Ltd
- Title
- Composed by Recalls Watch from fields of the record; FDA records have no title.